Hos patienter, som fik foretaget en ikke- primær PCI mindre end 6 timer efter sidste fondaparinuxdosis, var den mediane UFH- dosis 5. 000 IE, og incidensen af svær blødning var 4, 1% (2/ 49).
In those patients who underwent non-primary PCI < 6 hours after the last dose of fondaparinux, the median dose of UFH was 5,000 IU and the incidence of major bleeding was 4.1% (2/ 49).